Mucosal and submucosal lesions of gastrointestinal tracts
Conditions
Interventions
experimental group:use protective gel
Control group:Conventional treatment
Sponsors
The First Affiliated Hospital, College of Medicine, Zhejiang University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Gastroenterology patients with esophagus and intestinal endoscopic mucosal resection wounds >= 2 cm, requiring wound protection, and successfully completed endoscopic surgery; 2. Aged 18-80 years, gender is not limited; there is still a slight bleeding wound after the bleeding is stopped by clinical standard hemostasis procedures such as ligation, electrocoagulation, and slight compression; 3. The intended operation site is the primary operation; there is no active bleeding; there is no perforation of the esophagus wall and intestinal wall; and the informed consent is signed voluntarily.
Exclusion criteria
Exclusion criteria: 1. Patients with active infection or severe systemic disease; 2. Severe liver function or cardiopulmonary function damage; those with coagulation or bleeding dysfunction; 3. Patients who are pregnant or breastfeeding; those who have received glucocorticoid therapy within 6 weeks (excluding inhalers and eye drops); 4. Use of drugs that may affect the blood coagulation system within 1 week: such as platelet receptor antagonist abciximab, tirofiban, clopidogrel and other anticoagulant or procoagulant drugs; acid allergy patients; 5. Other patients who are not suitable for the operation of this product.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| healing rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse event;ulcer area; | — |
Countries
China
Contacts
Public ContactShen Zhe
Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University
Outcome results
None listed